Literature DB >> 34159170

Hepatocellular carcinoma (HCC) risk stratification after virological cure for hepatitis C virus (HCV)-induced cirrhosis: time to refine predictive models.

Raoel Maan1, Adriaan J van der Meer1.   

Abstract

Entities:  

Year:  2021        PMID： 34159170      PMCID： PMC8188127          DOI： 10.21037/hbsn-21-95

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  12 in total

1.  Long-Term Risk of Hepatocellular Carcinoma in HCV Patients Treated With Direct Acting Antiviral Agents.

Authors:  Fasiha Kanwal; Jennifer R Kramer; Steven M Asch; Yumei Cao; Liang Li; Hashem B El-Serag
Journal:  Hepatology       Date:  2019-08-19       Impact factor: 17.425

Review 2.  EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.

Authors: 
Journal:  J Hepatol       Date:  2018-04-05       Impact factor: 25.083

3.  Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients With Baseline Cirrhosis or High FIB-4 Scores.

Authors:  George N Ioannou; Lauren A Beste; Pamela K Green; Amit G Singal; Elliot B Tapper; Akbar K Waljee; Richard K Sterling; Jordan J Feld; David E Kaplan; Tamar H Taddei; Kristin Berry
Journal:  Gastroenterology       Date:  2019-07-26       Impact factor: 22.682

4.  Personalized surveillance for hepatocellular carcinoma in cirrhosis - using machine learning adapted to HCV status.

Authors:  Etienne Audureau; Fabrice Carrat; Richard Layese; Carole Cagnot; Tarik Asselah; Dominique Guyader; Dominique Larrey; Victor De Lédinghen; Denis Ouzan; Fabien Zoulim; Dominique Roulot; Albert Tran; Jean-Pierre Bronowicki; Jean-Pierre Zarski; Ghassan Riachi; Paul Calès; Jean-Marie Péron; Laurent Alric; Marc Bourlière; Philippe Mathurin; Jean-Frédéric Blanc; Armand Abergel; Olivier Chazouillères; Ariane Mallat; Jean-Didier Grangé; Pierre Attali; Louis d'Alteroche; Claire Wartelle; Thông Dao; Dominique Thabut; Christophe Pilette; Christine Silvain; Christos Christidis; Eric Nguyen-Khac; Brigitte Bernard-Chabert; David Zucman; Vincent Di Martino; Angela Sutton; Stanislas Pol; Pierre Nahon
Journal:  J Hepatol       Date:  2020-06-29       Impact factor: 25.083

5.  Hepatic Fat-Genetic Risk Score Predicts Hepatocellular Carcinoma in Patients With Cirrhotic HCV Treated With DAAs.

Authors:  Elisabetta Degasperi; Enrico Galmozzi; Serena Pelusi; Roberta D'Ambrosio; Roberta Soffredini; Marta Borghi; Riccardo Perbellini; Floriana Facchetti; Massimo Iavarone; Angelo Sangiovanni; Luca Valenti; Pietro Lampertico
Journal:  Hepatology       Date:  2020-11-20       Impact factor: 17.425

6.  A Model Based on Noninvasive Markers Predicts Very Low Hepatocellular Carcinoma Risk After Viral Response in Hepatitis C Virus-Advanced Fibrosis.

Authors:  Sonia Alonso López; María Luisa Manzano; Francisco Gea; María Luisa Gutiérrez; Adriana Maria Ahumada; María José Devesa; Antonio Olveira; Benjamin Arturo Polo; Laura Márquez; Inmaculada Fernández; Juan Carlos Ruiz Cobo; Laura Rayón; Daniel Riado; Sonia Izquierdo; Clara Usón; Yolanda Real; Diego Rincón; Conrado M Fernández-Rodríguez; Rafael Bañares
Journal:  Hepatology       Date:  2020-11-10       Impact factor: 17.425

7.  Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.

Authors:  Adriaan J van der Meer; Bart J Veldt; Jordan J Feld; Heiner Wedemeyer; Jean-François Dufour; Frank Lammert; Andres Duarte-Rojo; E Jenny Heathcote; Michael P Manns; Lorenz Kuske; Stefan Zeuzem; W Peter Hofmann; Robert J de Knegt; Bettina E Hansen; Harry L A Janssen
Journal:  JAMA       Date:  2012-12-26       Impact factor: 56.272

Review 8.  Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies.

Authors:  Rebecca L Morgan; Brittney Baack; Bryce D Smith; Anthony Yartel; Marc Pitasi; Yngve Falck-Ytter
Journal:  Ann Intern Med       Date:  2013-03-05       Impact factor: 25.391

Review 9.  We need stronger evidence for (or against) hepatocellular carcinoma surveillance.

Authors:  Peter Jepsen; Joe West
Journal:  J Hepatol       Date:  2021-01-17       Impact factor: 25.083

10.  HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response.

Authors:  Nourdine Hamdane; Frank Jühling; Emilie Crouchet; Houssein El Saghire; Christine Thumann; Marine A Oudot; Simonetta Bandiera; Antonio Saviano; Clara Ponsolles; Armando Andres Roca Suarez; Shen Li; Naoto Fujiwara; Atsushi Ono; Irwin Davidson; Nabeel Bardeesy; Christian Schmidl; Christoph Bock; Catherine Schuster; Joachim Lupberger; François Habersetzer; Michel Doffoël; Tullio Piardi; Daniele Sommacale; Michio Imamura; Takuro Uchida; Hideki Ohdan; Hiroshi Aikata; Kazuaki Chayama; Tujana Boldanova; Patrick Pessaux; Bryan C Fuchs; Yujin Hoshida; Mirjam B Zeisel; François H T Duong; Thomas F Baumert
Journal:  Gastroenterology       Date:  2019-03-02       Impact factor: 33.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.